H15.05 Scleromalacia perforans

Name of the Condition

• Scleromalacia perforans
• Medical Term: Scleromalacia perforans
• ICD Code: H15.05

Summary

Scleromalacia perforans is a rare, necrotizing condition of the sclera, the tough outer layer of the eyeball, characterized by thinning and potential perforation. It often occurs in the setting of long-standing rheumatoid arthritis and may lead to serious ocular complications if not addressed. The condition requires careful evaluation to assess structural integrity and underlying systemic associations.

Causes

Scleromalacia perforans is most commonly associated with severe, long-standing rheumatoid arthritis, particularly in patients with seropositive disease. Other systemic inflammatory or autoimmune conditions may rarely contribute. The exact pathophysiology involves scleral necrosis, likely driven by immune complex deposition or vasculitis affecting the scleral vasculature.

Risk Factors

• Long-standing rheumatoid arthritis (especially seropositive)
• Chronic systemic inflammation
• Advanced age
• Female gender (more prevalent in women)

Symptoms

• Painless scleral thinning or visible scleral translucency
• Possible visible uveal tissue (e.g., choroid) through thinned sclera
• Asymptomatic in early stages; may progress to perforation
• Rarely, associated with ocular pain or redness if inflammation is present

Diagnosis

Diagnosis is based on clinical examination, including slit-lamp assessment for scleral thinning or perforation. Ancillary tests may include imaging (e.g., ultrasound biomicroscopy) to evaluate scleral integrity. Systemic workup for underlying rheumatoid arthritis or other autoimmune conditions is often warranted, given the strong association.

Treatment Options

Management focuses on addressing underlying rheumatoid arthritis with systemic immunosuppression (e.g., disease-modifying antirheumatic drugs). Local measures may include protective eyewear to prevent trauma. Surgical intervention is rarely needed but may be considered for perforation or severe thinning.

Prognosis and Follow-Up

Prognosis depends on the extent of scleral damage and control of underlying disease. Early detection and treatment of rheumatoid arthritis can stabilize the condition. Regular ophthalmologic follow-up is essential to monitor for progression or complications.

Complications

• Scleral perforation
• Uveal prolapse
• Vision loss (if perforation or inflammation affects the retina)
• Secondary infection

Lifestyle & Prevention

• Manage rheumatoid arthritis with prescribed medications to reduce systemic inflammation.
• Avoid eye trauma; use protective eyewear if at risk.
• Maintain regular ophthalmologic and rheumatologic care.

When to Seek Professional Help

Seek prompt evaluation if you notice changes in eye appearance (e.g., visible thinning, discoloration) or experience new ocular symptoms, especially if you have a history of rheumatoid arthritis.

Tips for Medical Coders

Code H15.05 is specific to scleromalacia perforans. Documentation should clearly indicate the presence of scleral necrosis or perforation and any associated systemic conditions (e.g., rheumatoid arthritis) to support the diagnosis. Ensure the code aligns with clinical findings and avoid using this code for non-perforating scleritis or other scleral disorders.